Former RCMP Chief Superintendent Derek Ogden designs a level 10 secure facility with sophisticated pharmaceutical-grade security measures setting the standard for medical marijuana facilities in Canada.

Ottawa, ON – Oct.29, 2014 – Vida Cannabis Corp. Spearheaded by Vida’s Chief Operating Officer – 27 year RCMP veteran Derek Ogden — Vida Cannabis Corp. is leading the development of state of the art purity, safety and security in the Canadian Medical Marijuana industry.

“Security at our facility, our staff’s safety and the integrity of our products are all key priorities that must be provided for,” says Derek Ogden, Vida Cannabis Chief Operating Officer. “We’re setting the highest standards at Vida’s advanced new clean-growth facility by designing in the same ‘level -10’ multi-layered security measures that safeguard the world’s most precious treasures and sensitive installations.”

Security measures at Vida’s 315,000 sq. ft. clean growth facility in Stellarton, Nova Scotia will include:

  • Authorized-access only employee flow management
  • Lab-style “clean in; clean out” measures mean all employees shower and gown-up before entering work areas ensuring that no pests or pathogens enter the building
  • Employees will wear clothing devoid of pockets, eliminating inadvertent contamination, and any chance of product diversion
  • Access screening of employees includes: biometrics, retinal scans plus card access denial if the supervisor is not present
  • 100 % HD camera 24 hour surveillance inside and outside the entire facility
  • Onsite 24/7 security personnel have the ability to see everywhere at all times via monitoring stations
  • Video recordings stored for 2 years following Health Canada requirements
  • 3-metre tall barbed wire fencing anchored at 2-metre depth
  • A high security 200-ton vault on site for product storage

Chief Operating Officer Derek Ogden has designed and is in the process of installing the elite measures to assure the ultimate in security, 100% pristine growing conditions and uninterrupted quality at Vida Cannabis. Ogden earned his security credentials working with the best in the business. During a distinguished RCMP career he served as Officer in Charge of Drug Enforcement and Director General of the Drugs and Organized Crime branch, where he commanded 1300 investigators. He has also worked closely with Health Canada and the Departments of Defense and Justice plus the private sector where he implemented security for tobacco industry facilities across North America.

“We could not have found a more qualified individual to ensure that all our operations exceed Health Canada MMRP security requirements,” says Greg Wilson, CEO of Vida Cannabis. “Derek has unrivalled security experience which includes implementing the highest level security protocols both with the RCMP and in private Industry. Since leaving the RCMP, he’s served as Director of Security for Canada’s largest tobacco company, and has consulted on security projects in Canada, the United States and Europe. He is simply the ideal choice to make sure our operations function safely and without disruption to produce the finest quality medicine. Derek’s skills are a vital part of our mission to create leadership positioning for Vida across Canada in all critical areas of the medical marijuana industry.”

About Vida Cannabis: Vida Cannabis Corp. is working to develop uniquely high quality solutions to meet customer needs in the growing global marketplace for legal cannabis-based products. Initial operations are centered in the Canadian market, where the Federal Government has established national guidelines enabling best-in-class producers to acquire commercial production licenses for medicinal purposes. Vida has assembled one of the top management teams in the world, and has extensive access to expertise and resources in the United States, Canada and Europe. Its 315,000-square-foot production facility, located in Stellarton, Nova Scotia will be one of the largest, most advanced medical marijuana facilities in Canada.


Media Contact:
Scott Ledingham
PR MediaNow


On behalf of the board,

Greg Wilson – Chairman & CEO
Vida Cannabis Corp.

Investor Relations

Toll free +1 800 593 1585
Direct: +1 647 560 4482


This announcement does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell, a solicitation to purchase, or advice on investments in any securities of Vida Cannabis Corp. (“Vida Cannabis”). Offers and solicitations shall be expressly identified as such and made in compliance with applicable securities laws. This announcement is for information purposes only. It should not be relied upon as a basis for investment decisions. You should consult with your own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of any investments you are considering. Whilst the information provided here is believed to be reliable, it cannot be guaranteed. It may contain forward-looking statements made by or on behalf of Vida Cannabis about its business or financial objectives, position, strategies or expectations. Such forward-looking statements may be identified by words such as, or similar to, “intends,” “anticipates,” “believes,” “expects” and “hopes” and includes, without limitation, the development of production facilities, approval from regulatory authorities and the ability for Vida Cannabis to obtain adequate financing to meet its business objectives. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. The statements in this announcement do not guarantee future performance. Vida Cannabis does not undertake any obligation to update any information provided in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned subsidiary of Vida Cannabis, must obtain approval from Health Canada in order to operate as a licensed commercial producer under the Marihuana for Medical Purposes Regulations. Vida Cannabis makes no representations or warranties that it will receive Health Canada approval.

Leave a Comment